Legal Representation
Attorney
Devon E. White
USPTO Deadlines
Application History
34 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 16, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Feb 16, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Aug 3, 2020 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
Aug 3, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Aug 3, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Jul 29, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 28, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 28, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 28, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Apr 28, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Apr 28, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 9, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Apr 9, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Mar 24, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Mar 24, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
Aug 28, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 26, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 26, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Aug 26, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 16, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 19, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 19, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 30, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 11, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
Dec 18, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Dec 17, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 17, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 17, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Dec 12, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 12, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
Dec 12, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
Dec 12, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
Sep 7, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Sep 1, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Software as a service (SAAS) services featuring software for precision oncology drug library screening; Product research and development, namely, testing of the newest drugs through high-throughput smart-screening platform to determine the best pharmacological treatments for an individual patient; Pharmacological product research consultation services that will enable others, namely, doctors and clinicians, to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing
First Use Anywhere:
Sep 16, 2019
First Use in Commerce:
Sep 16, 2019
Class 044
Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Genetic counseling; Genetic testing for medical purposes; Health care services for treating cancer; Medical analysis services for the diagnosis of cancer; Providing personalized healthcare and medical information in the nature of providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing, individual behaviors including medication compliance, exercise, diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis
First Use Anywhere:
Sep 16, 2019
First Use in Commerce:
Sep 16, 2019
Classification
International Classes
042
044